IFP Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $800K | Sell |
1,590
-1,074
| -40% | -$540K | 0.02% | 651 |
|
2025
Q1 | $1.3M | Sell |
2,664
-92
| -3% | -$44.8K | 0.04% | 479 |
|
2024
Q4 | $1.11M | Buy |
2,756
+909
| +49% | +$367K | 0.04% | 501 |
|
2024
Q3 | $859K | Sell |
1,847
-457
| -20% | -$212K | 0.03% | 517 |
|
2024
Q2 | $1.08M | Buy |
2,304
+328
| +17% | +$154K | 0.04% | 422 |
|
2024
Q1 | $826K | Sell |
1,976
-159
| -7% | -$66.4K | 0.04% | 460 |
|
2023
Q4 | $869K | Buy |
2,135
+354
| +20% | +$144K | 0.04% | 417 |
|
2023
Q3 | $619K | Sell |
1,781
-73
| -4% | -$25.4K | 0.03% | 520 |
|
2023
Q2 | $652K | Buy |
1,854
+289
| +18% | +$102K | 0.03% | 558 |
|
2023
Q1 | $238K | Sell |
1,565
-5,339
| -77% | -$812K | 0.01% | 878 |
|
2022
Q4 | $1.1M | Sell |
6,904
-1,343
| -16% | -$214K | 0.03% | 590 |
|
2022
Q3 | $1.29M | Buy |
8,247
+711
| +9% | +$111K | 0.03% | 550 |
|
2022
Q2 | $1.17M | Hold |
7,536
| – | – | 0.04% | 531 |
|
2022
Q1 | $1.17M | Buy |
7,536
+6,426
| +579% | +$994K | 0.04% | 531 |
|
2021
Q4 | $245K | Sell |
1,110
-54
| -5% | -$11.9K | ﹤0.01% | 850 |
|
2021
Q3 | $213K | Buy |
1,164
+154
| +15% | +$28.2K | ﹤0.01% | 893 |
|
2021
Q2 | $198K | Sell |
1,010
-814
| -45% | -$160K | ﹤0.01% | 913 |
|
2021
Q1 | $400K | Sell |
1,824
-421
| -19% | -$92.3K | 0.01% | 593 |
|
2020
Q4 | $533K | Buy |
2,245
+19
| +0.9% | +$4.51K | 0.02% | 488 |
|
2020
Q3 | $613K | Buy |
2,226
+945
| +74% | +$260K | 0.04% | 388 |
|
2020
Q2 | $372K | Buy |
1,281
+286
| +29% | +$83.1K | 0.03% | 478 |
|
2020
Q1 | $223K | Buy |
995
+309
| +45% | +$69.3K | 0.02% | 543 |
|
2019
Q4 | $152K | Sell |
686
-66
| -9% | -$14.6K | 0.01% | 759 |
|
2019
Q3 | $125K | Buy |
+752
| New | +$125K | 0.01% | 956 |
|
2019
Q1 | $83K | Sell |
452
-954
| -68% | -$175K | 0.01% | 760 |
|
2018
Q4 | $227K | Sell |
1,406
-230
| -14% | -$37.1K | 0.01% | 811 |
|
2018
Q3 | $315K | Buy |
1,636
+577
| +54% | +$111K | 0.01% | 866 |
|
2018
Q2 | $180K | Buy |
1,059
+345
| +48% | +$58.6K | 0.01% | 1111 |
|
2018
Q1 | $107K | Hold |
714
| – | – | ﹤0.01% | 1345 |
|
2017
Q4 | $107K | Sell |
714
-148
| -17% | -$22.2K | ﹤0.01% | 1342 |
|
2017
Q3 | $131K | Buy |
862
+158
| +22% | +$24K | 0.01% | 1386 |
|
2017
Q2 | $91K | Sell |
704
-2
| -0.3% | -$259 | ﹤0.01% | 1565 |
|
2017
Q1 | $77K | Sell |
706
-65
| -8% | -$7.09K | ﹤0.01% | 1663 |
|
2016
Q4 | $57K | Buy |
771
+108
| +16% | +$7.98K | ﹤0.01% | 1797 |
|
2016
Q3 | $58K | Sell |
663
-9
| -1% | -$787 | ﹤0.01% | 1708 |
|
2016
Q2 | $58K | Buy |
672
+220
| +49% | +$19K | ﹤0.01% | 1676 |
|
2016
Q1 | $83K | Sell |
452
-315
| -41% | -$57.8K | 0.01% | 760 |
|
2015
Q4 | $97K | Buy |
+767
| New | +$97K | 0.01% | 1190 |
|